Biologics and Biological Implants

Award Date 9/28/2018
Last Date To Order 9/26/2023
Shared Ceiling $4.2B
Federal Agency
Headquarters
Contract Type
Master IDIQ
Predecessor
Not listed
Successors

The Biologics and Biological Implants Indefinite Delivery/Indefinite Quantity (IDIQ) contract, issued by the Department of Veterans Affairs (VA) Strategic Acquisition Center, is designed to procure a wide range of biologics and biological implants for VA medical facilities nationwide. The contract covers human cell, tissue, and cellular-based products, as well as animal-derived products used for prosthetic and therapeutic purposes. These products include allografts from human cadavers, xenografts from animals, surgical implants, vascular grafts, stents, and various medical devices intended to restore body functions, replace tissues, or support surgical procedures.

The task orders under this IDIQ are predominantly issued to small businesses like Era Health LLC and Academy Medical Inc., with contract values typically ranging from $10,000 to $100,000 and performance periods spanning 2-4 months. Most delivery orders are funded by specific Veterans Integrated Service Networks (VISN) and are not set aside, though occasional service-disabled veteran-owned small business (SDVOSB) sole source awards occur. Common places of performance include medical centers in Texas, New York, and Florida, with prime contractors supplying products such as abdominal aortic aneurysm endoprostheses, shoulder and hip implants, nerve stimulators, and surgical meshes. The contract supports the VA's mission of providing specialized medical equipment and implants to support veteran healthcare services across the United States.

Generated 1/16/25, 12:03 AM